Clinical trials
Trials in Georgia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
103 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 3 |
| 2011 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 20 |
| 2022 | 19 |
| 2023 | 12 |
| 2024 | 11 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Recruiting | 22 |
| Unknown status | 15 |
| Active, not recruiting | 10 |
| Not yet recruiting | 4 |
| Terminated | 4 |
| Withdrawn | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 4 |
| Foundation for Innovative New Diagnostics, Switzerland | 4 |
| BrainsGate | 3 |
| Pharmanutra S.p.a. | 3 |
| VisCardia Inc. | 3 |
| AVeta Medical | 2 |
| Alleviant Medical, Inc. | 2 |
| Atrian Medical Ltd. | 2 |
| Axon Therapies, Inc. | 2 |
| BelkinVision | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 18 |
| Atrial Fibrillation | 9 |
| Coronary Artery Disease | 5 |
| Ischemic Stroke | 5 |
| Mitral Valve Insufficiency | 5 |
| Cardiovascular Diseases | 4 |
| Hypertension | 4 |
| Stroke | 4 |
| Colorectal Neoplasms | 3 |
| Diabetes Mellitus, Type 2 | 3 |
Trials
Showing 51 to 75 of 103. Each trial links to its page on Pharma Observatory.
3 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.